|
Volumn 127, Issue 1-3, 2002, Pages 245-249
|
What do we want from proteomics in the detection and avoidance of adverse drug reactions
|
Author keywords
Adverse drug reactions; Microarrays; Pharmacogenomics; Proteomics
|
Indexed keywords
FIBRIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
SEROTONIN UPTAKE INHIBITOR;
ADULT;
BIOPSY;
BLOOD SAMPLING;
CASE REPORT;
CLINICAL FEATURE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DISEASE COURSE;
GENE EXPRESSION;
HUMAN;
IN VITRO STUDY;
JAUNDICE;
MALAISE;
MALE;
NAUSEA;
PHARMACOGENOMICS;
PREDICTION;
PRIORITY JOURNAL;
PROTEOMICS;
SAFETY;
GENE EXPRESSION REGULATION;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PROTEOME;
TOXICOLOGY;
|
EID: 0037186911
PISSN: 03784274
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4274(01)00506-9 Document Type: Conference Paper |
Times cited : (20)
|
References (13)
|